The evolution of neurofilament light chain in multiple sclerosis

C Ferreira-Atuesta, S Reyes, G Giovanonni… - Frontiers in …, 2021‏ - frontiersin.org
Multiple sclerosis (MS) is an autoimmune, inflammatory neurodegenerative disease of the
central nervous system characterized by demyelination and axonal damage. Diagnosis and …

N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology

JR Moffett, B Ross, P Arun, CN Madhavarao… - Progress in …, 2007‏ - Elsevier
The brain is unique among organs in many respects, including its mechanisms of lipid
synthesis and energy production. The nervous system-specific metabolite N-acetylaspartate …

Cortical demyelination and diffuse white matter injury in multiple sclerosis

A Kutzelnigg, CF Lucchinetti, C Stadelmann, W Brück… - Brain, 2005‏ - academic.oup.com
Focal demyelinated plaques in white matter, which are the hallmark of multiple sclerosis
pathology, only partially explain the patient's clinical deficits. We thus analysed global brain …

Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia

SK Song, SW Sun, WK Ju, SJ Lin, AH Cross… - Neuroimage, 2003‏ - Elsevier
Both axon and myelin degeneration have significant impact on the long-term disability of
patients with white matter disorder. However, the clinical manifestations of the neurological …

Demyelination increases radial diffusivity in corpus callosum of mouse brain

SK Song, J Yoshino, TQ Le, SJ Lin, SW Sun, AH Cross… - Neuroimage, 2005‏ - Elsevier
Myelin damage, as seen in multiple sclerosis (MS) and other demyelinating diseases,
impairs axonal conduction and can also be associated with axonal degeneration. Accurate …

Pathology of multiple sclerosis and related inflammatory demyelinating diseases

A Kutzelnigg, H Lassmann - Handbook of clinical neurology, 2014‏ - Elsevier
This article provides a comprehensive overview of the pathology of multiple sclerosis (MS),
including recent insights into its molecular neuropathology and immunology. It shows that all …

Gait and balance impairment in early multiple sclerosis in the absence of clinical disability

CL Martin, BA Phillips, TJ Kilpatrick… - Multiple Sclerosis …, 2006‏ - journals.sagepub.com
This study evaluated the gait and balance performance of two clinically distinct groups of
recently diagnosed and minimally impaired multiple sclerosis (MS) patients (Expanded …

A basic overview of multiple sclerosis immunopathology

N Grigoriadis, V Van Pesch - European journal of neurology, 2015‏ - Wiley Online Library
Multiple sclerosis (MS) is a multi‐component disease characterized by inflammation,
neurodegeneration and failure of central nervous system (CNS) repair mechanisms …

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

M Gunnarsson, C Malmeström, M Axelsson… - Annals of …, 2011‏ - Wiley Online Library
Objective: The impact of present disease‐modifying treatments (DMTs) in multiple sclerosis
(MS) on nerve injury and reactive astrogliosis is still unclear. Therefore, we studied the effect …

Evidence of early cortical atrophy in MS: relevance to white matter changes and disability

N De Stefano, PM Matthews, M Filippi, F Agosta… - Neurology, 2003‏ - neurology.org
Objective: To assess cortical gray matter (GM) changes in MS and establish their relevance
to clinical disability and to inflammatory changes of white matter (WM) in patients with the …